14.45USD-2.23%Mkt Cap: 928.86M $P/E: —1d ago
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherap…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap928.86M $
Enterprise Value677.34M $
Revenue (TTM)5.04M $
Gross Profit5.04M $
Net Income (TTM)-146.95M $
Revenue/Share0.0850 USD
Last Price14.45 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees170
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-26.72
PEG—
EV/EBITDA-3.88
EV/Revenue134.50
P/S177.71
P/B5.25
EPS (TTM)-3.37
EPS (Forward)-0.53
52W Range
14.1929% of range15.10
52W High15.10 USD
52W Low14.19 USD
Profitability
Gross Margin100.00%
Oper. Margin-7228.57%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-87.07%
ROA-62.87%
Growth
Revenue Growth-53.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-121.18M $
CapEx (TTM)538.00K $
FCF Margin-2081.96%
FCF Yield-11.29%
Net Debt-167.20M $
Net Debt/EBITDA0.96
Balance Sheet
Debt/Equity0.05
Current Ratio3.72
Quick Ratio3.54
Book Value/Sh2.710 USD
Cash/Share2.955 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:2
Split DateJun 7, 2024
Analyst Consensus
Rating—
Target (Mean)41.73 USD
Upside (mean)+188.8%
Target Range5.948 USD – 56.25 USD
$5.948+188.8% to mean$56.25
# Analysts6
Ownership
Shares Out.62.85M
Float34.94M
Insiders0.00%
Institutions40.98%
Short Interest
Short Ratio6.4d
Short % Float3.13%
Short % Out.3.12%
Shares Short1.85M
Short (prev mo.)1.30M
Technical
SMA 5015.11 (-4.3%)
SMA 20018.13 (-20.3%)
Beta-0.24
S&P 52W Chg18.16%
Avg Vol (30d)220.61K
Avg Vol (10d)283.84K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—